We are live on ! Find out more
EIM

Essex Investment Management Portfolio holdings

AUM $632M
1-Year Est. Return 95.36%
This Fund
S&P 500
This Quarter Est. Return
+31.23%
1 Year Est. Return
+95.36%
3 Year Est. Return
+271.62%
5 Year Est. Return
+354.98%
10 Year Est. Return
+3,586.14%
AUM
$550M
AUM Growth
+$70.6M
Cap. Flow
-$37M
Cap. Flow %
-6.73%
Top 10 Hldgs %
19.32%
Holding
327
New
24
Increased
23
Reduced
152
Closed
29

Top Buys

Rank Stock Value
1
MIRM icon
Mirum Pharmaceuticals
MIRM
+$5.02M
2
GEV icon
GE Vernova
GEV
+$2.92M
3
COHU icon
Cohu
COHU
+$2.47M
4
MAMA icon
Mama's Creations
MAMA
+$2.39M
5
ORN icon
Orion Group Holdings
ORN
+$2.25M

Top Sells

Rank Stock Value
1
NUTX
Nutex Health
NUTX
+$7.08M
2
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$6.56M
3
TVTX icon
Travere Therapeutics
TVTX
+$4.56M
4
GNRC icon
Generac Holdings
GNRC
+$3.88M
5
GWRE icon
Guidewire Software
GWRE
+$3.34M

Sector Composition

Rank Sector Weight
1 Industrials 30.33%
2 Technology 26.01%
3 Healthcare 18.4%
4 Financials 6.04%
5 Consumer Staples 4.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRK icon
226
Merck
MRK
$332B
$89.6K 0.02%
1,132
– –
CINF icon
227
Cincinnati Financial
CINF
$26.6B
$81.8K 0.01%
549
– –
AWRE icon
228
Aware
AWRE
$26.6M
$81.5K 0.01%
43,105
-510
-1% -$844
WAB icon
229
Wabtec
WAB
$49.7B
$75.8K 0.01%
362
– –
NTIC icon
230
Northern Technologies International Corp
NTIC
$76.8M
$74.5K 0.01%
10,059
-120
-1% -$917
PM icon
231
Philip Morris
PM
$297B
$73.2K 0.01%
402
– –
GKOS icon
232
Glaukos
GKOS
$11B
$63.1K 0.01%
611
– –
NVT icon
233
nVent Electric
NVT
$27.5B
$61.7K 0.01%
842
– –
RGLD icon
234
Royal Gold
RGLD
$19.4B
$60.1K 0.01%
338
+111
+49% +$19.6K
GOOG icon
235
Alphabet (Google) Class C
GOOG
$4.22T
$56.8K 0.01%
320
– –
FCX icon
236
Freeport-McMoran
FCX
$95.3B
$56.2K 0.01%
1,297
– –
UG icon
237
United-Guardian
UG
$33.6M
$56.1K 0.01%
7,013
-82
-1% -$678
DOW icon
238
Dow Inc
DOW
$21.9B
$54.1K 0.01%
2,043
– –
EXEL icon
239
Exelixis
EXEL
$12.5B
$53.3K 0.01%
1,210
– –
NTNX icon
240
Nutanix
NTNX
$17.7B
$52.4K 0.01%
686
– –
BMY icon
241
Bristol-Myers Squibb
BMY
$132B
$51.8K 0.01%
1,120
– –
MS icon
242
Morgan Stanley
MS
$349B
$51.1K 0.01%
363
– –
DD icon
243
DuPont de Nemours
DD
$19.5B
$49K 0.01%
570
– –
JNJ icon
244
Johnson & Johnson
JNJ
$628B
$48.7K 0.01%
319
– –
ITRI icon
245
Itron
ITRI
$4.47B
$47.6K 0.01%
362
– –
GTES icon
246
Gates Industrial Corporation Ltd.
GTES
$7.01B
$46K 0.01%
1,996
– –
WEC icon
247
WEC Energy
WEC
$35.8B
$44.8K 0.01%
430
– –
CLH icon
248
Clean Harbors
CLH
$16.8B
$44.6K 0.01%
193
– –
WMB icon
249
Williams Companies
WMB
$90.1B
$42.7K 0.01%
680
– –
PPL
250
PPL Corp
PPL
$26.9B
$42K 0.01%
1,238
– –
8 9
10
11 12

Similar funds

BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
AP
Affinity Partners Sunny Isles Beach, Florida $635M AUM 43.43% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
WCM
Woodson Capital Management Greenwich, Connecticut $636M AUM 39.33% 1-Year Est. Return
FTC
Farmers Trust Company Youngstown, Ohio $637M AUM 23.14% 1-Year Est. Return

Essex Investment Management's Q2 2025 Portfolio in Review

As of Q2 2025, Essex Investment Management held 327 positions worth $550M, up 15% from $479M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Essex Investment Management withdrew a net $37M in Q2 2025, closing 29 positions and reducing 152 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $6.56M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 30% of assets, up from 25% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Essex Investment Management opened a new position in Mirum Pharmaceuticals worth $5.74M.

  • Essex Investment Management's largest Q2 2025 buy was Mirum Pharmaceuticals: 112,731 shares worth $5.74M.
  • Essex Investment Management added most to GE Vernova in Q2 2025, an estimated $2.92M increase.
  • Essex Investment Management's biggest Q2 2025 reduction was Nutex Health, cutting an estimated $7.08M.
  • Essex Investment Management fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $6.56M.
  • Essex Investment Management's ten largest holdings make up 19% of its $550M portfolio in Q2 2025.
  • Essex Investment Management opened 24 new positions and closed 29 in Q2 2025.
  • Essex Investment Management's portfolio value rose 15% quarter-over-quarter to $550M.

Based on Essex Investment Management's 13F filing for Q2 2025, filed 12 Aug 2025.